SCHEMBL7003147

SCHEMBL7003147

COC(=O)c1nn(CCN2CCOCC2)c(C(=O)OC)c1N

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 3/20 0.41
GAA P10253 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HPGD P15428 2/20 0.41
GLA P06280 1/20 0.41
CNR2 P34972 2/20 0.41
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
CNR1 P21554 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7003153 0.93 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL7001412 0.81 GAA (0.49) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL7001420 0.77 GAA (0.47) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL2769301 0.72 LMNA (0.47) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL7002038 0.71 LMNA (0.40) SMN1; SMN2LMNACNR1
SCHEMBL31133143 0.71 NPSR1 (0.43) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL331349 0.70 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL6807697 0.70 CCNA2 (0.37) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL20670974 0.69 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL6443054 0.68 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1KDM4EGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123296-B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LTD (GB) 2003-09-17 EP disclosed
US-6333330-B1 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. 2001-12-25 US disclosed
EP-1123296-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2001-08-16 EP disclosed
WO-2000024745-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 2000-05-04 WO disclosed